The impact of Medicaid expansion in 2014 on prescription second-generation antidepressant utilization in Washington State: An interrupted time series analysis
Background Depressive disorders, specifically major depressive disorder (MDD), is predicted to become the leading cause of disease burden worldwide by 2030. In the United States, MDD is already the leading cause of disability. Yet, less than 50 percent of US adults diagnosed with a mental disorder seek treatment, often due to lack of health coverage or affordability. In 2014, the Affordable Care A